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Abstract
Study design Observational cohort study.
Objective To benchmark all-cause and cause-speciﬁc mortality following NTSCI to the general population (GP).
Setting Specialized rehabilitation centers in Switzerland.
Methods Longitudinal data from the Swiss Spinal Cord Injury (SwiSCI) Medical Record study were probabilistically linked
with cause of death (CoD) information from the Swiss National Cohort. Standardized mortality ratios (SMRs) were
estimated for all-cause and cause-speciﬁc mortality. Competing risk frameworks were used to estimate the probability of
death due to speciﬁc CoD.
Results One thousand ﬁve hundred and one individuals were admitted for ﬁrst rehabilitation with NTSCI between
1990–2011; CoD information was available for 454 individuals of the 525 individuals that died. Overall, the mortality rate
for persons with NTSCI was 1.6 times greater than that of the GP. Deaths due to cardiovascular disease (39.8%), neoplasms
(22%), and infection (9.9%) were most often reported. Individuals with an SCI due to a vascular etiology indicated the
greatest burden of mortality from infection compared with the GP (SMR 5.4; 95% CI, 3.1 to 9.2).
Conclusions Cause-speciﬁc SMRs varied according to etiology. This supports the need for targeted clinical care and follow-
up. Cardiovascular disease, neoplasms, and infection, emerged as main causes of death following NTSCI and should thus be
targets for future research and differential clinical management approaches.
Introduction
The global incidence of non-traumatic spinal cord injuries
(NTSCIs) has seen a marked increase in recent years, and
this is forecasted to continue given a globally aging popu-
lation [1]. Although epidemiological evidence for NTSCI is
limited, the WHO recently summarized a report which
estimated the worldwide incidence to vary between 12 and
76 per million population [2]. However, critical epidemio-
logical indicators, instrumental to informing long-term
patient management and health policy—including mortal-
ity—remain scarce for NTSCI [3]. While most of the cur-
rently available literature focuses on traumatic SCI (TSCI)
[4, 5], this evidence is often not transposable to NTSCI due
to the distinct, often age-related pathologies associated with
NTSCI. This lack of evidence renders evidence-based
clinical decisions, prognosis, patient education, and
resource allocation for the NTSCI population particularly
challenging [3, 6, 7].
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Considering the etiologically heterogeneous and elderly
composition of the NTSCI population [1, 3], identiﬁcation
of subgroups suitable for targeted interventions are essential
for minimizing within-group mortality differentials and
improvement of the overall health system [8]. All-cause and
cause-speciﬁc mortality estimates allow for the investiga-
tion of the burden of mortality associated to NTSCI by
highlighting risk factors that contribute to an increased risk
of mortality and speciﬁc cause of death (CoD). In addition,
benchmarking the mortality burden in NTSCI with the
general population (GP) could facilitate improvement in
health system’s resource allocation and models of care
through the identiﬁcation of differences in mortality and
CoD relative to NTSCI characteristics and etiology.
Therefore, the objective of this study is to estimate the
relative risk of all-cause and cause-speciﬁc mortality in
NTSCI with reference to the GP in Switzerland.
Methods
Study description
Data for the present study were collected from the Medical
Records study of the Swiss Spinal Cord Injury (SwiSCI)
cohort study, which includes all SCI-speciﬁc rehabilitation
centers in Switzerland from 1990 to 2011 [9]. Eligibility for
study inclusion was new cases of NTSCI admitted to
rehabilitation in individuals of at least 16 years of age.
Cases of NTSCI due to congenital disorders (e.g., spina
biﬁda) or progressive disorders, such as multiple sclerosis
and Guillain–Barre syndrome were excluded from the
SwiSCI study.
Data management
Data pertaining to CoD following NTSCI from the SwiSCI
cohort were linked with the Swiss National Cohort (SNC)
using probabilistic record linkage [10]; birthdate, date of
death, age, sex, and geocoded address were used for linkage
[4]. In total, 85.5% of SwiSCI records were linked, 92.4%
of the linked data had no alternative matches. For linkages
with multiple potential matches, a linkage weight was used
to assess linkage quality. All main analyses included within
the present study, used records with the highest weighted
linkage; alternative linkages were used in sensitivity ana-
lysis to assess the potential inﬂuence of the alternative
mortality record linkage with CoD-related estimates, parti-
cularly for cause-speciﬁc standardized mortality ratios
(SMRs).
NTSCI etiologies were categorized according to a hier-
archical classiﬁcation strategy described in the “International
SCI core data sets for NTSCI” [11] and grouped into the
following categories: “degenerative disc disorder,” “infec-
tion,” “vascular disorder,” “benign tumor,” and “malignant
tumor.” Individuals that developed an NTSCI from an
unclear origin, metabolic disorders, inﬂammatory disease,
and radiation-related causes were grouped into an “other”
category. Tumor-related NTSCIs without a speciﬁed tumor
status (i.e., malignant or benign) were excluded from all
statistical analyses (n= 10). SCI-related characteristics
comprised “lesion level” (paraplegia/tetraplegia) and “lesion
completeness” (incomplete/complete). A combined variable
categorized as “lesion severity” comprised of lesion level
and completeness (e.g., paraplegia-incomplete, paraplegia-
complete, tetraplegia-incomplete, tetraplegia-complete),
according to the “International Spinal Cord Injury core data
set” guidelines [12].
Information on cause of death were based on doc-
umentation from death certiﬁcates obtained from the link-
age with the SNC. Cause of death was mainly coded using
International classiﬁcation of diseases (ICD) version 10. 11
cases were originally coded using ICD version 8 and sub-
sequently matched with ICD-10 codes based on name and
description (ICD version 9 was never implemented in the
Swiss healthcare system). In line with other CoD studies,
the underlying cause of death, deﬁned as the disease or
injury that initiated the course of events leading directly to
death was utilized in all analyses [13, 14]. With the
exception of descriptive statistics, CoD was categorized into
four main subgroups based on contemporary mortality
studies that have implemented death certiﬁcate data [4, 14],
namely: “cardiovascular disease (CVD),” “infection,”
“neoplasm,” and “other.” The CVD category included:
death due to cardiac disease, ischemic heart disease, cere-
bral circulatory disease, pulmonary circulatory disease, as
well as other circulatory disease while the neoplasm cate-
gory included both benign and malignant tumors. The
infection disease category comprised deaths due to
respiratory infection, urinary infection, infectious disease,
or septicemia. The “other” category additionally included
all other causes of death including digestive-related dis-
eases. Information on the population distribution of NTSCI
etiological groups was presented previously [15].
Statistical analysis
Descriptive statistics include raw numbers and percentages
to evaluate differences in causes of death across major
etiological subgroups. To prevent misinterpretation and
skewed results, subsequent estimates excluded NTSCIs of
malignant origin, as reported CoD pertaining to these cases
was almost exclusively due to a neoplasm. Negative bino-
mial regression was used to estimate SMRs and
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corresponding conﬁdence intervals for all-cause mortality
using age-, sex-, and calendar year-speciﬁc mortality rates
from the Swiss GP as offset. Cumulative incidence over 21
years of follow-up was estimated within a competing risk
framework for estimation of cause-speciﬁc subhazard ratios
(sHRs) using the Fine and Gray model [16].
Multiple imputation via chained equations was used to
account for potential bias due to missing information in
completeness of lesion and lesion level; data were presumed
missing at random. The imputation model included all
predictor variables used in regression modeling (e.g., sex,
age category, lesion level, lesion completeness, decade of
SCI, NTSCI etiology), as well as relevant parameters of the
outcome (i.e., vital status indicator [yes/no] and the log of
survival time) [17]. Twenty imputed data sets were created
to replace missing values [18]; estimates generated from
imputed data sets were combined using Rubin’s rules to
derive global estimates [19].
All analyses were implemented using Stata software
version 14.2 for Windows (College Station, TX). Further-
more, the methodology and results were reported according
to the recommendations outlined in the Strengthening the
Reporting of Observational Studies in Epidemiology
(STROBE) guidelines [20].
Results
Participant characteristics
The present study includes 1501 persons diagnosed with an
NTSCI between January 1st, 1990 and September 30th,
2011, with a cumulative person-time of 7457 person-years
and 525 individuals with a known date of death. Informa-
tion on cause of death was available for 454 individuals.
All-cause mortality
The all-cause mortality risk for persons with NTSCI with
respect to the GP are shown in Table 1. The overall mor-
tality rate for individuals with NTSCI was estimated to be
1.6 times greater than that of the GP in Switzerland. Indi-
viduals in the youngest age category had the highest mor-
tality rate with reference to the GP (SMR= 20.7; 95% CI,
4.1–37.3). Cases of NTSCI due to infection had a mortality
rate 2.5 times greater than the GP (95% CI,1.5–3.5), while
those with vascular etiology had an SMR of 1.7 (95% CI,
1.3–2.1) (Table 1). Individuals with complete lesions were
estimated to have a mortality burden over three times
greater than that of the GP (SMR= 3.2; 95% CI, 2.0–4.3),
while lesion level was not associated with elevated
mortality.
Cause-speciﬁc mortality
Table 2 summarizes main causes of death in the cohort over
the entire study period stratiﬁed by whether malignant or
nonmalignant etiology of NTSCI. CVDs were the most
commonly reported CoD in nonmalignant NTSCI etiologies
(39.8%) followed by neoplasms (21.7%). In addition,
digestive-related diseases accounted for 6.3% of deaths
following NTSCI. Table S1 presents cause of death strati-
ﬁed by NTSCI etiology. 36.7% of deaths in individuals with
an NTSCI due to a degenerative disc disorder were due to
CVD, while 22% of deaths in this group were related to
neoplasms. Furthermore, cause of death in individuals with
an NTSCI due to malignant tumors were almost exclusively
related to neoplasms (Table S2). Therefore cancer-speciﬁc
causes of death in individuals with NTSCI due to a
malignant neoplasm are additionally presented in Table S2.
39.5% of deaths due to neoplasms were speciﬁcally from a
Table 1 All-cause SMRs (for all nonmalignant NTSCI etiological
groups)
Characteristics SMR (95% CI) P-value
Overall 1.62 (1.34–1.90)
Sex 0.18
Male 1.72 (1.39–2.04)
Female 1.43 (1.08–1.78)
Age category <0.001
16–30 20.7 (4.14–37.3)
31–45 5.33 (2.18–8.48)
45–60 2.63 (1.74–3.51)
61–75 1.57 (1.27–1.88)
75+ 1.10 (0.91–1.29)
Lesion level 0.60
Paraplegia 1.65 (1.34–1.96)
Tetraplegia 1.53 (1.13–1.94)
Completeness <0.001
Incomplete 1.43 (1.18–1.68)
Complete 3.15 (2.03–4.27)
Lesion severity <0.001
Paraplegia, incomplete 1.43 (1.13–1.72)
Paraplegia, complete 2.98 (1.82–4.13)
Tetraplegia, incomplete 1.40 (1.01–1.78)
Tetraplegia, complete 6.18 (0.92–11.44)
Etiology <0.001
Degenerative disc disorder 1.10 (0.81–1.39)
Infection 2.53 (1.53–3.53)
Vascular disorder 1.73 (1.34–2.12)
Benign tumor 1.46 (0.86–2.06)
Other 3.20 (1.71– 4.68)
SMR standardized mortality ratio
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sex-speciﬁc neoplasm, followed by “neoplasms of lym-
phoid hematopoietic tissue” at 19.7%.
Differential mortality
Cause-speciﬁc mortality rates according to NTSCI etiology
and lesion completeness are presented in Table 3. Com-
pared with the general population, individuals with an
NTSCI due to a degenerative disc disorder were over three
times more likely to die of infection (SMR= 3.2; 95% CI,
1.7–5.9), (Table 3). In addition, persons with degenerative
disc disorders exhibited elevated mortality rates from CVD
1.6 times greater than that of the GP (95% CI, 1.1–2.3).
Persons with an NTSCI originating from a vascular disorder
experienced an elevated risk of mortality due to CVD
(SMR= 4.1; 95% CI, 3.2–5.3). However, the greatest
burden of mortality identiﬁed in this vascular etiological
group was due to infection (SMR= 5.4; 95% CI, 3.1–9.2).
For individuals with an infection-related NTSCI, death due
to infection was elevated with respect to the general
population (SMR= 4.4; 95% CI, 1.4–13.5) (Table 3).
Cause-speciﬁc SMRs were elevated across most etiological
groups in individuals with a complete lesion. For example,
among individuals with a vascular-related NTSCI,
infection-related SMRs were roughly double for complete
lesions in comparison with incomplete lesions (SMR= 9.6;
95% CI, 4.0–23.0 and SMR= 4.32; 95% CI, 2.3–8.3,
respectively) (Table 3). Similar SMRs were estimated for
the respective cause of death group according to NTSCI
etiology when using alternative linkages (Table S4).
Competing risks
sHRs for competing risks of mortality are presented in
Table 4. Age was a prominent risk factor for all major
causes of death. An elevated risk of mortality associated
with the original NTSCI etiology was apparent within each
CoD category. For example, the sHR for mortality due to
CVD was elevated for vascular-related NTSCIs (sHR=
1.80; 95% CI, 1.01–3.11). Similarly, for mortality due to
Table 2 Cause of death stratiﬁed
by NTSCI etiology:
nonmalignant etiology
compared with malignant tumor
Nonmalignant etiologiesa Malignant tumor
Cause of death (ICD-10 code) n (%) n (%)
Respiratory infection (J00-J22) 12 (4.4) 1 (0.5)
Chronic obstructive pulmonary disease (J40–J47) 7 (2.6) 0 (0.0)
Other respiratory disease (J30–J99) 7 (2.6) 0 (0.0)
Cardiac disease (I05–I09, I11; I30–I59) 20 (7.4) 2 (1.1)
Ischemic heart disease (I20–I25) 34 (12.5) 1 (0.5)
Cerebral, circulatory disease (I60–I69) 19 (7.0) 2 (1.1)
Pulmonary, circulatory disease (I26–I28) 2 (0.7) 0 (0.0)
Other circulatory disease (I10; I12–I15; I70–I99) 19 (7.0) 1 (0.5)
Neoplasms (C00-D49) 59 (21.7) 157 (87.7)
Urinary infection (N30–N39) 4 (1.5) 0 (0.0)
Renal failure (N17–N19) 3 (1.1) 0 (0.0)
Other urogenital (N00–N16, N20; N40–N99) 2 (0.7) 0 (0.0)
Digestive-related disease (K00–K95) 17 (6.3) 1 (0.5)
Suicide (X71–X83) 4 (1.5) 4 (2.2)
Accidents (S00-T88; V00-X58) 5 (1.8) 0 (0.0)
Skin-related disease (L00–L99) 1 (0.4) 0 (0.0)
Infectious disease (A00-B99, excl. A41) 6 (2.2) 2 (1.1)
Septicemia (A41) 5 (1.8) 0 (0.0)
Ill-deﬁned (R00-R99) 8 (2.9) 3 (1.6)
Nervous system-related disease (G00–G99) 15 (5.5) 0 (0.0)
Endocrine-related disease (E00–E89) 10 (3.7) 2 (1.1)
Musculoskeletal-related disease (M00–M99) 8 (2.9) 2 (1.1)
Mental-related disease (F01–F99) 4 (1.5) 0 (0.0)
Immune-, blood-, eye/ear-related disease (D50–D89;
H00–H59)
1 (0.4) 1 (0.5)
Total 272 (100) 179 (100)
aNonmalignant etiological groups include: degenerative disc disorder, infection, vascular disorder, benign
tumors, and other
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neoplasms, a greater sHR was estimated for individuals
with a benign tumor NTSCI etiology (sHR 4.0; 95% CI,
1.8–8.6).
Discussion
All-cause and cause-speciﬁc mortality
Compared with the general population, mortality rates were
1.6 times greater in the NTSCI population. Cause-speciﬁc
SMRs varied greatly between etiological groups and
according to lesion completeness. A particularly vulnerable
group identiﬁed in the present study were individuals with
an NTSCI due to an infection, who experienced a greater
burden of infection-related mortality. These results indicate
that individuals with infection pathology potentially sustain
an immunodeﬁciency beyond treatment for NTSCI, which
may contribute to their mortality following injury. Fur-
thermore, individuals with an NTSCI due to a vascular
disorder had a greater risk of mortality due to a CVD,
suggesting that underlying health conditions resulting in
NTSCI play a critical role in the mortality in addition to the
spinal cord lesion [21].
Differential mortality
Estimates from this study highlight the potential inﬂuence
of NTSCI etiology on differential causes of death. For
example, deaths due to CVDs were most common in this
population and may be attributable to treatable health
conditions, such as hypertension, obesity, or dyslipidemia
[22]. Injury-related dysreﬂexia and orthostatic hypotension
may further contribute to reduced life expectancy due to
CVD [23]. Our results are supported by ﬁndings from a
population-based community survey that looked at per-
ceived health conditions following SCI in Switzerland;
44% of participants with NTSCI reported circulatory pro-
blems, and over 25% experienced autonomic dysreﬂexia
[24]. In addition, the burden of mortality due to digestive-
related diseases was greater in the NTSCI population
compared with the GP. Competing risk analyses investi-
gating risk of mortality due to digestive-related diseases
was not possible given the diverse categorization of CoDs
Table 3 Cause-speciﬁc SMRs
stratiﬁed by NTSCI
etiological groups
Cause of deatha
CVD Infectionb Neoplasm Otherc
NTSCI etiology
Degenerative disc disorder
Total 1.62 (1.13–2.32) 3.19 (1.72–5.92) 1.45 (0.91–2.30) 1.52 (0.94–2.44)
Incomplete lesion 1.53 (1.05–2.21) 3.22 (1.73–5.99) 1.47 (0.93–2.34) 1.54 (0.96–2.47)
Complete lesion 3.88 (1.46–10.35) 5.55 (0.78–39.38) 2.31 (0.58–9.24) 4.22 (1.36–13.08
Infection etiology
Total 1.49 (0.67–3.33) 4.36 (1.41–13.51) 2.16 (0.97–4.81) 6.09 (3.67–10.11)
Incomplete lesion 1.13 (0.42–3.02) 3.31 (0.83–13.24) 1.65 (0.62–4.39) 5.03 (2.79–9.09)
Complete lesion 4.92 (1.85–13.10) 7.13 (1.00–50.62) 3.62 (0.90–14.47) 8.30 (3.12–22.13)
Vascular disorder
Total 4.12 (3.20–5.32) 5.36 (3.11–9.22) 1.45 (0.88–2.41) 2.06 (1.30–3.26)
Incomplete lesion 3.51 (2.60–4.73) 4.32 (2.25–8.31) 1.59 (0.94–2.68) 1.86 (1.10–3.13)
Complete lesion 6.07 (3.87–9.51) 9.55 (3.97–22.94) 0.47 (0.07–3.32) 3.93 (1.87–8.25)
Benign tumor
Total 0.51 (0.16–1.58) – 3.77 (2.35–6.07) –
Incomplete lesion – – 3.63 (2.22–5.92) –
Complete lesion – – 4.23 (1.06–16.93) –
Other etiology
Total 4.18 (2.25–7.77) – 1.60 (0.52–4.95) 7.31 (3.93–13.58)
Incomplete lesion 4.64 (2.42–8.92) – 1.89 (0.61–5.86) 7.10 (3.55–14.19)
Complete lesion 3.43 (0.86–13.72) – 2.69 (0.38–19.12) 9.88 (3.19–30.62)
CVD cardiovascular diseases
aCause of death are grouped into the most common categories
bThe CoD “Infection” includes respiratory infections, urinary infections, septicemia, in addition to all other
infectious disease (A00-B99)
cAll other causes of death are grouped into the “other” category
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in this group which includes alcoholic cirrhosis of the liver,
perforation of the intestine, as well as duodenal ulcers.
However, persons with NTSCI were found to have a nearly
11 times higher rate of mortality from a digestive-related
CoD (SMR 10.9 95% CI, 6.8–17.5) in comparison with the
GP (Table S3). This enhanced burden of mortality
experienced by the NTSCI population for digestive-related
CoDs may be partly due to the multimorbid nature of
NTSCI, related to a predisposition to gastrointestinal dis-
orders in addition; obesity and alcoholism may further
enhance the burden within this community [25, 26].
Personalized rehabilitation and long-term follow-up
programs
Long-term follow-up care and etiology-speciﬁc, tailored
treatments could potentially reduce complications from
secondary health conditions and improve survival outcomes.
A recent study found that individuals with a nonmalignant
NTSCI can expect ~10–12 life years remaining with an
attained age of 60 years, underscoring the importance of
long-term follow-up care for this population [15]. In addi-
tion, patient education that enables individuals with NTSCI
and their caretakers to effectively seek care and take care in
preventative methods (e.g., low-impact exercise, dietary
intervention, and pressure sore prevention) could potentially
minimize the development of secondary complications and
lower the risk of mortality and improve quality of life [27].
Healthcare systems and NTSCI management models must
consider the differential prognoses and mortality outcomes
identiﬁed between NTSCI etiological groups to aid in the
development of specialized inpatient and outpatient rehabi-
litation programs. For example, individuals with progressive
forms of NTSCI (e.g., malignant and benign tumors) can
beneﬁt from short-term rehabilitation plans, with optimized
goals, aimed at improving vital aspects of functioning (e.g.,
bladder management and caretaker education) [28–30].
Individuals with an infection and cardiovascular etiology
additionally require intensive routine checks and up-to-date
vaccinations to minimize medical complications that can
interfere with rehabilitation [31]. Specialized outpatient
follow-up care can play a vital role for the prevention and
treatment of complications secondary to NTSCI [29]. Out-
patient services, such as the Swiss-based ParaHelp [32],
can provide individuals with NTSCI with quality advice
and counseling and reduce patient burden associated with
Table 4 Competing risk analysis
of risk factors for cause-speciﬁc
mortality
Cause of death
Cardiovascular diseases
(n= 108)
Infection (n= 27) Neoplasms (n= 59)
Characteristics sHR (95% CI) P-value sHR (95% CI) P-value sHR (95% CI) P-value
Age at injury
<60 years Ref. <0.0001 Ref. 0.09 Ref. 0.05
60–75 years 3.85 (2.00–7.41) 3.33
(1.11–9.99)
2.11
(1.10–4.04)
75+ years 8.26
(4.20–16.23)
2.74
(0.80–9.34)
2.18
(0.99–4.78)
Lesion level
Paraplegia Ref. 0.44 Ref. 0.77 Ref. 0.87
Tetraplegia 0.81 (0.48–1.38) 1.15
(0.45–2.90)
1.05
(0.57–1.97)
Completeness
Incomplete Ref. 0.11 Ref. 0.05 Ref. 0.58
Complete 1.65 (0.90–3.03) 2.82
(1.00–8.01)
0.74
(0.25–2.17)
NTSCI etiology
Degenerative disc
disorder
Ref. 0.01 Ref. 0.82 Ref. <0.01
Infection 0.58 (0.20–1.66) 1.21
(0.31–4.65)
1.55
(0.59–4.09)
Vascular disorder 1.80 (1.04–3.11) 1.14
(0.43–3.07)
1.10
(0.50–2.43)
Benign tumor 0.39 (0.12–1.29) 0.41
(0.05–3.23)
3.98
(1.84–8.64)
sHR subhazard ratio
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in-clinic follow-up. Specialized healthcare approaches are
needed for the successful management of NTSCIs across the
disease continuum, from initial diagnosis to long-term
community care and support, to facilitate improved health
outcomes and reduce etiology-speciﬁc disparities.
Strengths and limitations
A major strength of this study is that it used data from a
multicenter rehabilitation cohort, providing a clear sampling
frame of people who were admitted to ﬁrst rehabilitation in
Switzerland over a 21-year study period. Furthermore,
stratiﬁcation of NTSCI etiological groups for all analyses
allows for comparison of mortality outcomes between
groups. This study is one of the ﬁrst population-based stu-
dies of relative mortality following NTSCI.
The study design targeted individuals that were admitted
for ﬁrst rehabilitation, therefore the portion of individuals
that never receive specialized rehabilitation or treatment are
less represented [3, 5], which can limit the generalizability
of results to the entire population with NTSCI. Thus, SMRs
of individuals not admitted to specialized care may be even
higher. Another potential limitation is that information on
cause of death relied solely on the accuracy of reporting
practices on death certiﬁcates. However, the uncertainty
regarding the reporting of CoD would likely have been
comparable in the general population, resulting in minimal
bias due to differential mortality in CoD coding [33].
Although there is no ofﬁcial protocol to identify analogous
codes between ICD 8 and ICD 10, this study only includes
11 cases coded using ICD version 8, therefore we do not
expect a large impact on results. There is additional
uncertainty related to linkage reliability and quality [33].
However, this is unlikely to be differential, and would
therefore merely impact precision [4, 33]. Sensitivity ana-
lyses that checked alternative links did not identify mean-
ingful differences (Table S4). Many CoD groups included
limited cases, which were further reduced when stratiﬁed on
NTSCI-speciﬁc etiological groups. Thus, caution is required
when drawing conclusions from SMRs in groups with small
sample sizes. Collaborative efforts in NTSCI with respect to
mortality outcomes in high income settings are needed to
improve statistical power, potentially in the form of multi-
national studies with longer follow-up time to improve
inference. Finally, linkage with cancer registries could
provide a basis for mortality comparisons in individuals
with NTSCI from a neoplastic origin.
Conclusion
Cause-speciﬁc mortality differentials identiﬁed between
NTSCI etiological groups indicate a need for specialized
rehabilitation strategies that align NTSCI-speciﬁc treatment
with care for underlying health conditions. Furthermore,
research involving neurorehabilitation and healthcare stra-
tegies following NTSCI that includes initiatives for redu-
cing risk of CVD, infections, and gastrointestinal
dysfunction is needed to optimize morbidity and mortality
outcomes.
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